Tamoxifen-loaded polylactide beads for breast tissue engineering following lumpectomy

Tissue Engineering and Regenerative Medicine

Volumn 8, Issue 3, 2011, Pages 282-291

  Xu, Feng ^a,b,c   Gomillion, Cheryl T ^a   Neser, Katherine ^a   Burg, Karen J L ^a  

^a Clemson University   (United States)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Microcarrier; Polylactide; Tamoxifen; Tissue engineering

Indexed keywords

ADIPOGENIC DIFFERENTIATIONS; EMULSION SOLVENT EVAPORATION; HUMAN BREAST CANCER CELLS; HUMAN MESENCHYMAL STEM CELLS (HMSCS); MICROCARRIERS; NEOADJUVANT CHEMOTHERAPIES; POLY LACTIDE; TAMOXIFEN;

BIOLOGICAL MEMBRANES; CHEMOTHERAPY; CYTOLOGY; DISEASES; EMULSIFICATION; ENCAPSULATION; POLYESTERS; REPAIR; STEM CELLS; TISSUE ENGINEERING;

TISSUE;

EID: 84884637097     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. A Jemal, R Siegel, J Xu, et al., Cancer statistics, 2010, CA Cancer J Clin, 60, 277 (2010).
2. CW Patrick Jr., Tissue engineering strategies for adipose tissue repair, Anat Rec, 263, 361 (2001).
3. E Billings Jr., JW May Jr., Historical review and present status of free fat graft autotransplantation in plastic and reconstructive surgery, Plast Reconstr Surg, 83, 368 (1989).
4. D von Heimburg, M Kuberka, R Rendchen, et al., Preadipocyteloaded collagen scaffolds with enlarged pore size for improved soft tissue engineering, Int J Artif Organs, 26, 1064 (2003).
5. R Ashinoff. Overview: soft tissue augmentation, Clin Plast Surg, 27, 479 (2000).
6. CW Patrick Jr., Adipose tissue engineering: the future of breast and soft tissue reconstruction following tumor resection, Semin Surg Oncol, 19, 302 (2000).
7. CW Patrick. Breast tissue engineering, Annu Rev Biomed Eng 6, 109 (2004) .
8. D von Heimburg, K Hemmrich, S Zachariah, et al., Oxygen consumption in undifferentiated versus differentiated adipogenic mesenchymal precursor cells, Respir Physiol Neurobiol, 146, 107 (2005).
9. KJ Burg, WD Holder Jr., CR Culberson, et al., Comparative study of seeding methods for three-dimensional polymeric scaffolds, J Biomed Mater Res, 51, 642 (2000).
10. JB McGlohorn, LW Grimes, SS Webster, et al., Characterization of cellular carriers for use in injectable tissue-engineering composites, J Biomed Mater Res A, 66, 441 (2003).
11. CT Gomillion, KJ Burg. Stem cells and adipose tissue engineering, Biomaterials, 27, 6052 (2006).
12. CC Yang, SE Ellis, F Xu, et al., In vitro regulation of adipogenesis: tunable engineered tissues, J Tissue Eng Regen Med, 1, 146 (2007).
13. EP Mamounas, Facilitating breast-conserving surgery and preventing recurrence: aromatase inhibitors in the neoadjuvant and adjuvant settings, Ann Surg Oncol, 15, 691 (2008).
14. R Nakamura, T Nagashima, M Sakakibara, et al., Breastconserving surgery using supine magnetic resonance imaging in breast cancer patients receiving neoadjuvant chemotherapy, Breast, 17, 245 (2008).
15. C Markopoulos, Safely promoting breast-conserving surgery and preventing early relapses with an aromatase inhibitor, Surg Oncol, 17, 113 (2008).
16. R Bodmeier, JW McGinity, The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method, Pharm Res, 4, 465 (1987).
17. Y Hong, C Gao, Y Xie, et al., Collagen-coated polylactide microspheres as chondrocyte microcarriers, Biomaterials 26, 6305 (2005).
18. SA Ahmed, RM Gogal Jr., JE Walsh, A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay, J Immunol Methods, 170, 211 (1994).
19. J Folch, M Lees, GH Sloane Stanley, A simple method for the isolation and purification of total lipides from animal tissues, J Biol Chem, 226, 497 (1957).
20. FF Xu, LB Xiao, WH Wu, et al., [Laparoscopic versus open appendectomy in patients with chronic appendicitis], Zhonghua Wei Chang Wai Ke Za Zhi, 10, 359 (2007).
21. KD Newman, MW McBurney, Poly(D, L lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells, Biomaterials, 25, 5763 (2004).
22. RR Perry, Y Kang, B Greaves, Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells, Ann Surg Oncol, 2, 238 (1995).
23. HK Dhiman, AR Ray, AK Panda, Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen, Biomaterials, 26, 979 (2005).
24. EP Gelmann, Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma, Semin Oncol, 24, S1- 65-S1-70 (1997).
25. AS Heerdt, PI Borgen, Current status of tamoxifen use: an update for the surgical oncologist, J Surg Oncol, 72, 42 (1999).
26. P Lehenkari, V Parikka, TJ Rautiala, et al., The effects of tamoxifen and toremifene on bone cells involve changes in plasma membrane ion conductance, J Bone Miner Res, 18, 473 (2003).
27. PC Calder, DJ Harvey, CM Pond, et al., Site-specific differences in the fatty acid composition of human adipose tissue, Lipids, 27, 716 (1992).
28. M Rautalahti, L Hyvonen, D Albanes, et al., Effect of sampling site on fatty acid composition of human breast adipose tissue, Nutr Cancer, 14, 247 (1990).
29. ZR Zhu, J Agren, S Mannisto, et al., Fatty acid composition of breast adipose tissue in breast cancer patients and in patients with benign breast disease, Nutr Cancer, 24, 151 (1995).
30. K Nesaretnam, PA Gomez, KR Selvaduray, et al., Tocotrienol levels in adipose tissue of benign and malignant breast lumps in patients in Malaysia, Asia Pac J Clin Nutr, 16, 498 (2007).
31. ES White, FE Baralle, AF Muro, New insights into form and function of fibronectin splice variants, J Pathol, 216, 1 (2008).
32. Y Shiba, S Yamada, Y Kanno, Survival of 3T3-L1 cells induced by fibroblast growth factor depends on cell density and adhesion to the substratum, Cell Struct Funct, 14, 473 (1989).
33. C McCaig, CM Perks, JM Holly, Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin, J Cell Sci, 115, 4293 (2002).